PTPRC and neoplasm: Unlike in tumor, there was no significant changes of CD45+, CD3+, CD4+T and CD8+T proportion in Spleen and Lymph Nodes for both BT942 and their combination except for CD8+ population percentage in Spleen by combination (Supplementary Fig. S7).